Investors Grab CRSP 7.4% Cheaper Than Its Secondary Stock Offering
September 24, 2018 at 10:04 AM EDT
Looking back to 4 days ago, CRISPR Therapeutics AG (CRSP) priced a 4,210,526 share secondary stock offering at $47.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..